Two 25-μg doses of the mRNA-1273 vaccine were found to be safe in children 6 months to 5 years of age and elicited immune responses that were noninferior to those in young adults. (Funded by the Biomedical Advanced Research and Development Authority and National Institute of Allergy and Infectious Diseases; KidCOVE ClinicalTrials.gov number, NCT04796896.).
No takes yet. Share an insight, caveat, or question.
Anderson et al. (2022) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: